Genus plc operates globally to supply superior genetics for the dairy, beef, and pork industries. The company's business is primarily divided into two segments: PIC, which specializes in pig genetics, and ABS, which focuses on bovine genetics. Genus utilizes cutting-edge biotechnology, including genomics and gene editing, to develop proprietary breeding lines that improve animal health, fertility, and yield. Headquartered in Basingstoke, UK, the company serves farmers in over 80 countries, generating revenue through the sale of semen, embryos, breeding animals, and licensing fees. Genus also maintains a dedicated R&D division to manage its research pipeline, including the development of disease-resistant livestock such as PRRS-resistant pigs.
